Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Drug Development

      TrakCel and WindMIL Therapeutics partner on cell therapy supply chain management and orchestration platform

      Drug Development
      TrakCel, the software developer for cell and gene therapy supply chain tracking and orchestration systems, and WindMIL Therapeutics, a clinical stage oncology cell therapy...

      Neovasc Receives Approval to Proceed with Phase 2 of TIARA-II Study from Clinical Regulators in Germany and the UK

      FDA Approvals
      Neovasc Inc., a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for...

      Horizon Discovery and Rutgers University Form Exclusive Partnership to Develop Next Generation Novel Gene Editing Technology

      Drug Development
      Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, announces that it has entered into an exclusive strategic partnership...

      Aldeyra Therapeutics Expands Retinal Disease Pipeline with Acquisition of Helio Vision

      Drug Development
      Aldeyra Therapeutics, Inc. , a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases, announced...

      CStone receives CTA approval in China to start Phase I trial for FGFR4 inhibitor BLU-554 (CS3008)

      FDA Approvals
      CStone Pharmaceuticals announced that the National Medical Products Administration recently approved the clinical trial application (CTA) to start a Phase I clinical trial in...

      Amgen Receives NMPA Approval For Repatha In China To Reduce The Risk Of Cardiovascular Events

      FDA Approvals
      Amgen announced that the National Medical Products Administration (NMPA) has approved a new indication for Repatha as the first PCSK9 inhibitor in China for...

      Sanofi secures FDA approval for flu vaccine in children

      FDA Approvals
      Sanofi has received approval from the US FDA for 0.5ml Fluzone Quadrivalent vaccine to treat influenza in children aged between six and 35 months. Sanofi...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.